Kaposi's sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV-8), is a cancer-related human virus, classified as a member of the Gammaherpesvirinae subfamily. We report here the construction of a dual fluorescent-tagged KSHV genome (BAC16-mCherry-ORF45), which constitutively expresses green fluorescent protein (GFP) and contains the tegument multifunctional ORF45 protein as a fusion protein with monomeric Cherry fluorescent protein (mCherry). We confirmed that this virus is properly expressed and correctly replicates and that the mCherry-ORF45 protein is incorporated into the virions. Using this labeled virus, we describe the dynamics of mCherry-ORF45 expression and localization in newly infected cells as well as in latently infected cells undergoing lytic induction and show that mCherry can be used to monitor cells undergoing the lytic viral cycle. This virus is likely to enable future studies monitoring the dynamics of viral trafficking and tegumentation during viral ingress and egress.
K
aposi's sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV-8), is a cancer-related human virus which is classified as a member of the Gammaherpesvirinae subfamily (1) (2) (3) . Like all other herpesviruses, KSHV exhibits two alternative infection cycles, lytic and latent; both cycles are necessary for long-term persistence of KSHV and for its pathogenesis. Infection with KSHV begins with the attachment and entry of KSHV virions into the cell, while fusion of the viral envelope with endocytic vesicles releases the tegumented capsids into the cytoplasm. Incoming nucleocapsids then utilize motor proteins to reach the nuclear pores and release the viral genome into the nucleoplasm, where transcription of viral genes and viral genomic replication take place (4) . The virus may enter a productive lytic or nonproductive latent infection. The lytic cycle is characterized by a temporally regulated cascade of viral gene expression and viral DNA replication that culminates in the assembly, maturation, and release of newly synthesized virions. Latent infection, the common in vitro default replication program of KSHV, which involves the expression of a small set of viral genes and presence of viral episomes, can be established following the expression of a unique set of viral genes under nonpermissive cellular conditions (5) . Nevertheless, under conditions that induce the expression of the virally encoded regulatory protein RTA, the latent viral genome may reactivate and switch the viral genetic program toward productive infection (6) (7) (8) .
All mature herpesvirus particles have a characteristic multilayered architecture, including (i) an inner core containing the linear double-stranded viral genome, (ii) an icosahedral protein shell called the capsid, (iii) an outer lipid bilayer envelope spiked with viral glycoproteins, and (iv) a thick proteinaceous electron-dense layer designated the tegument, which is located between the nucleocapsid and the envelope. Herpesviral assembly is a multistage event consisting of the formation of capsids within the nucleus, packaging of the replicated viral DNA into the capsids, and exit from the nucleus to the cytoplasm via the acquisition of the primary envelope by budding through the inner nuclear membrane and its subsequent loss at the outer nuclear membrane. During primary envelopment, a portion of the tegument proteins are already bound to the nucleocapsid. In the cytoplasm, tegument proteins join the partially tegumented nucleocapsids, and the capsids are enveloped in the trans-Golgi apparatus. Final envelopment, including acquisition of additional tegument proteins, the lipid bilayer envelope, and viral glycoproteins, occurs through the budding into Golgi vesicles. Ultimately, virion-containing vesicles follow the secretory pathway to the cell membrane, and mature viral particles are released into the extracellular environment by exocytosis (9, 10) . The entire assembly course is regulated mainly by tegument proteins that sequentially interact with capsid, envelope, and cellular proteins at different intracellular locations during virus egress. Yet the molecular mechanisms that enable recruitment of tegument proteins to the nucleocapsid are poorly understood (11, 12) . In addition to their role during virus assembly and maturation, tegument proteins play important roles in various aspects of the virus lytic replication cycle, at the very early phases of infection, during progression of the infection, and at the late phases. Thus, tegument proteins are expressed at various cellular compartments, in which they mediate unique functions.
The assembly and egress mechanism of the gammaherpesviruses, in particular that of the KSHV virions, has only begun to be elucidated; however, it is assumed to share a course similar to that of other herpesviruses (13) (14) (15) (16) . Proteomic studies using mass spectrometry identified the ORF11, -21, -33, -45, -50, -63, -64, and -75 gene products as components of the KSHV tegument and together with a systematic investigation of the interactions between the KSHV virion proteins enabled schematic modeling of the outer and inner tegument organization (13, 17) . KSHV ORF45 is an immediate early tegument protein which has homologues only in the gammaherpesviruses. During infection, ORF45 is thought to be involved in several functions, including the antiviral response, regulation of the lytic cycle, and migration of capsids on microtubules. Disruption of ORF45 drastically reduces KSHV infectivity and progeny virion yields, though viral gene expression and DNA replication remain unaffected. This indicates a vital role for ORF45 in events leading to viral ingress and egress (18) .
In the present study, we used the full-length KSHV genome bacterial artificial chromosome 16 (BAC16) clone to construct a recombinant KSHV containing the monomeric Cherry fluorescent protein (mCherry) fused to the amino terminus of ORF45. We show that the new recombinant virus undergoes reactivation and produces infectious viruses upon reconstitution in human cells. Incorporation of mCherry-tagged ORF45 into assembling virions was as efficient as that of wild-type virus. We investigated the cellular compartmentalization of ORF45 and found that unlike that of the ectopically expressed protein, the localization of mCherry-ORF45 is dynamic along the infection process. Finally, we show that expression of mCherry-ORF45 can be used to track cells undergoing lytic infection.
MATERIALS AND METHODS
Cells. HEK-293T, SLK, and iSLK-PURO cells (kindly provided by Don Ganem and Rolf Renne) (19) were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum, 50 IU/ml penicillin, and 50 g/ml streptomycin (Biological Industries, Kibbutz Beit Haemek, Israel). Tet system-approved certified fetal bovine serum (Biological Industries, Kibbutz Beit Haemek, Israel), 250 g/ml G418, and 1 g/ml puromycin (A.G. Scientific, Inc.) were added to iSLK-PURO growth medium to maintain the Tet-On transactivator (Clontech) and RTA expression cassette, respectively.
Plasmids. The expression plasmids encoding green fluorescent protein (GFP)-ORF45 and hemagglutinin (HA)-ORF45 were previously described (20) .
Construction of BAC16 mCherry-ORF45 recombinant virus. BAC16 containing a recombinant full-length KSHV genome containing a GFP cassette under the control of EF-1␣ promoter has been previously described (21) . The construction of the mCherry-ORF45-expressing virus, BAC16-mCherry-ORF45, was accomplished using the GS1783 strain of Escherichia coli, which encodes inducible Red and I-Sce-I activities, with a two-step recombination protocol, as described previously (22) . To construct an mCherry cassette for recombination into the BAC16 genome (pEP-mCherry), we first generated a universal transfer plasmid based on a red fluorescent protein (RFP) cassette (pEP-mRFP1), which was kindly provided by Nikolaus Osterrieder (22) . Specifically, mCherry was amplified by PCR using 5=-AAAGAATTCATGGTGAGCAAGGGCGAGG AATGGTGAGCAAGGGCGAGGA-3= and 5=-AAAGGATCCCTTGT ACAGCTCGTCCATGCCGGCATGGACGAGCTGTACAAG-3= primers containing EcoRI and BamHI restriction sites and pmCherry-C1 (Clontech) as a template. The resulting PCR product was cloned into the pBluescript-KS plasmid following digestion with EcoRI and BamHI to produce the pBluescript-mCherry plasmid. A PstI fragment, containing a kanamycin resistance (Kan r ) cassette and an I-SceI restriction site, was then isolated from the pEP-mRFP1 plasmid and inserted into the PstI site of pBluescript-mCherry, resulting in a plasmid carrying a kanamycin resistance cassette and an I-SceI restriction site, flanked with mCherry containing a small internal duplication. The resulting plasmid was confirmed by nucleotide sequence analysis. This plasmid was then used as a PCR template to obtain a linear DNA fragment encompassing mCherry, a kanamycin resistance cassette, and an I-SceI restriction site and the flanking 47 bp of viral sequences from nucleotides (nt) 68393 to 68439 located upstream of the KSHV orf45 start codon. The primer set used to amplify this fragment was 5=-TGTGCTTTGTAAATTTCCGCCCCTAGCGGTC AACCCCGTACAAGGCCATGGTGAGCAAGGGCGAGGAGGATAA C-3= and 5=-ATTCTCTCTTCATCGTGTGTGCTAGACGAGGTCCTCA CAAACATCGCCTTGTACAGCTCGTCCATGC-3= (the mCherry start methionine codon is in boldface; the sequence homologous to that of mCherry is underlined). The methylated plasmid template was then digested by DpnI, and the agarose-purified PCR product of 1,736 bp was subsequently introduced by electroporation (0.1-cm cuvette, 1.8 kV, 200 ⍀, 25 F) into the GS1783 E. coli strain harboring BAC16, while the transient expression of gam, bet, and exo gene products required for homologous recombination was induced by incubation at 42°C. Cells were then plated on LB agar plates containing both chloramphenicol (17 g/ ml) and kanamycin (15 g/ml). Integration of the mCherry/Kan r /I-SceI cassette was verified by PCR and restriction enzyme digestion of the purified BAC16 DNA. Primers A and B located upstream of the orf45 gene (nt 68459 to 68440; 5=-GCAGTAAAGGCAATAACTCG-3=) and within the orf45 coding sequence (nt 67895 to 67912; 5=-AACCCATCCCATGG ACGC-3=), respectively, were used to amplify a diagnostic DNA fragment of 564 bp, whereas a DNA fragment of 2,256 bp was obtained, as predicted, after insertion of the mCherry/Kan r /I-SceI cassette. The integrated cassette was then cleaved upon treatment with 1% L-arabinose; a second recombination event between the duplicated sequences resulted in the loss Kan r /I-SceI cassette and recircularization of the BAC16 DNA, yielding kanamycin-sensitive colonies that were screened by replica plating, followed by diagnostic PCR as well as restriction enzyme digestion of the purified DNA. BAC DNA was purified by using a large-construct kit (Qiagen) according to the manufacturer's instructions. BAC DNA was digested with HindIII and SnaB1 and run on a 0.4% agarose gel. The inserted DNA fragment was sequenced to confirm the junction sequence at the insertion site.
Transfection of KSHV BAC16 DNA and virus reconstitution. For BAC16 transfection and reconstitution, ϳ70% confluent HEK-293T cells were grown in a 24-well plate followed by transfection with 500 ng of BAC DNA via Lipofectamine 2000 transfection reagent (Life Technologies, Invitrogen). Infected cells were selected in a medium which also contained 200 g/ml hygromycin B (A.G. Scientific, Inc.). Following selection of HEK-293T cells that carry recombinant viruses, these cells were subcultured and mixed at a 1:1 ratio with iSLK-PURO cells. After 24 h, the lytic virus cycle was induced by 20 ng/ml 12-O-tetradecanoylphorbol-13-acetate (TPA) and 1 mM sodium butyrate (Sigma). Selection medium containing 250 g/ml G418, 1 g/ml puromycin, and 1.2 mg/ml hygromycin B was added 4 days later, and iSLK-PURO cells infected with the recombinant viruses were established. KSHV-infected iSLK-PURO cells were treated with 1 g/ml doxycycline and 1 mM sodium butyrate or 1 mM valproic acid (Sigma), in the absence of hygromycin, puromycin, and G418, to induce RTA transgene expression and lytic cycle reactivation. To prepare virus stocks, 4 days after lytic induction, supernatant was collected and cleared of cells and debris by centrifugation (700 ϫ g for 10 min at 4°C) and filtration (0.45-m cellulose acetate filters; Corning). Virus particles were pelleted by centrifugation (40,000 ϫ g for 2 h at 4°C).
Quantification of infectious virus production. Cells were trypsinized, washed, and suspended in 0.5 ml phosphate-buffered saline (PBS); 0.5 ml 2% formaldehyde was added, and the cells were incubated at 4°C for 20 min. The cells were then washed with PBS, suspended in 1 ml of 70% ethanol, and incubated for 30 min at 4°C. Finally, cells were washed once and suspended in PBS. GFP-and mCherry-positive cells were determined using a fluorescence-activated cell sorter (FACS) (BD FACSAria III; BD Biosciences). Data analysis was performed with FlowJo software. This approach was used to measure virus reactivation and to quantitate infectious virions. Various volumes of cell-free virus were used to infect SLK cells that were seeded at approximately 10 5 cells/well in 24-well plates 24 h prior to infection. Cells were collected 48 h later and washed twice with cold PBS. The titer for each inoculum size, assuming that one infectious particle generates a single GFP-positive cell, was calculated as a percentage of the uninfected cells, according to Poisson's law, and expressed as infectious units/ml.
Purification and quantification of genomic DNA from infected cells and virions. High-molecular-weight (HMW) DNA was extracted using a mammalian genomic DNA miniprep kit (Sigma). Purified cell-free virus from supernatants was treated with TurboDNase (Ambion, Inc.) for 1 h at 37°C to eliminate nonencapsidated genomes. Virion DNA was extracted following proteinase K treatment by using a DNeasy blood and tissue kit (Qiagen). KSHV DNA was quantitated using a previously described TaqMan PCR employing primers and a probe targeting orf K6 (23, 24) with duplicates of 12 ng HMW DNA or 0.5, 1, and 5 l from each virion DNA preparation. A second quantitative TaqMan-based real-time PCR, detecting human endogenous RNaseP (TaqMan human RNaseP control kit, Applied Biosystems), was used as a normalization tool for HMW and to confirm DNA quality. The number of KSHV genomes in each sample was determined by comparison of the obtained threshold cycle (C T ) value to the corresponding value of the standard curve. All PCRs were performed using an Opticon2 real-time PCR (MJ Research, Inc., MA).
Antibodies and Western blot analysis. Cells were washed twice in cold PBS, suspended in radioimmunoprecipitation assay (RIPA) lysis buffer, and incubated on ice for 30 min. Cell debris was removed by centrifugation at 12,000 ϫ g for 15 min at 4°C. Virion proteins were extracted by suspension of the viral particles in sodium-dodecyl sulfate (SDS) loading buffer followed by 10 min of boiling. Protein lysates were resolved by SDS-PAGE and transferred to nitrocellulose membranes using a TransBlot Turbo RTA Midi nitrocellulose transfer kit (Bio-Rad). The protein content of different samples was verified by Ponceau S staining. The nitrocellulose membranes were blocked with 5% dry milk in Tris-buffered saline (TBS) and subsequently incubated with primary mouse antibodies to GFP (Covance Research Products), mCherry (catalog no. 632496; Clontech), glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (SC-25778; Santa Cruz), ORF45 (17) , ORF K8 (25) (kindly obtained from Yan Yuan), ORF65 (26) (kindly obtained from Shou Jiang Gao), or RTA (27) (kindly obtained from Keiji Ueda). Specific reactive bands were detected using anti-mouse conjugated to horseradish peroxidase. Immunoreactive bands were visualized using an EZ-enhanced chemiluminescence (ECL) detection kit (Biological Industries, Israel).
Fluorescence microscopy. Cells were seeded on coverslips and were either induced to undergo lytic reactivation or infected with purified virions by spinoculation (1,500 ϫ g, 1 h, 4°C). To reduce fluorescent background, medium without phenol red was used. At the indicated time points, cells were washed with PBS and fixed by incubation in 4% formaldehyde for 20 min at room temperature. The cells were then washed twice in PBS and permeabilized in PBS containing 0.2% Triton X-100 and 1% bovine serum albumin (BSA) at room temperature for 30 min. Cells were probed with primary antibody (mouse anti-HA [Covance Research Products], anti-ORF45, anti-ORF65, or anti-␣-tubulin [Sigma]) at 4°C, and a conjugated secondary antibody (anti-mouse Alexa Fluor 488, antimouse rhodamine red, or anti-mouse Alexa Fluor 647 [Jackson Laboratory]) was then applied for detection. To stain the nuclei, the cells were incubated for 30 min with 0.05 g/ml Hoechst dye (Sigma). For virion imaging, poly-L-lysine (Sigma)-coated coverslips were placed in a 24-well plate and overlaid with purified virions, and the plates were centrifuged at 1,500 ϫ g at 4°C for 1 h. Adhered virions were fixed with 4% formaldehyde, permeabilized by treatment with PBS containing 0.1% Triton X-100 and 1% BSA, and then probed with anti-ORF65 and stained with Hoechst dye. Cells and virions were examined and photographed under a confocal laser scanning microscope (Zeiss LSM 510 Meta). Cells for live imaging were plated on 35-mm-diameter glass-bottom dishes and induced to undergo lytic reactivation. Twenty-four hours later, dishes were placed in a humidified chamber supplied with 5% CO 2 and heated to 37°C that was mounted on a Zeiss Axio Observer.Z1 inverted fluorescence microscope. Cells were subsequently monitored for the appearance of mCherry, and individual cells were chosen for serial photodocumentation over a period of 26 h. Images at individual time points were taken, at an excitation wavelength of 582 nm and with a 595-nm emission filter with an exposure of 700 ms, by using an EC Plan-Neofluar 40ϫ objective with a 0.75 numerical aperture and an AxioCam HSm digital camera controlled by Zeiss AxioVision software. Differential interference contrast (DIC) images were also collected.
RESULTS

Construction of a recombinant KSHV BAC16 expressing N-terminal mCherry-tagged ORF45.
To construct a virus expressing the mCherry protein fused to the 5= end of KSHV ORF45, we took the advantage of the complete KSHV BAC16 clone, which enables genetic manipulation of the KSHV genome in E. coli. As previously described (21, 22 ) (see Materials and Methods), a BACbased two-step Red-mediated recombination system was used. The final virus, designated BAC16-mCherry-ORF45, was tested for the presence of the engineered insertion by diagnostic PCR and restriction enzyme analysis, with HindIII and SnaBI revealing similar DNA fragmentation patterns, with the exceptions of the 5,838-and 9,925-bp fragments predicted to undergo recombination, respectively. BAC16-mCherry-ORF45 contained the expected 6,546-and 10,633-bp restriction fragments compared to the wild-type BAC16, respectively. No additional differences were observed between the BAC16 and BAC16-mCherry-ORF45 viral DNAs following restriction enzyme digestion (Fig. 1) . To further confirm that faithful recombination had occurred, we PCR amplified and sequenced genomic DNA, including the boundary of the targeting sequence used for allelic exchange. These experiments established that the recombinant genome contains the correct insertion, with no evident rearrangements.
The BAC16-mCherry-ORF45 exhibits functional properties similar to those of wild-type BAC16. To reconstitute infectious viruses from the recombinant BAC16-mCherry-ORF45 DNA, HEK-293T cells were transfected with BAC16 or BAC16-mCherry-ORF45 DNA, selected with hygromycin, and cocultivated with iSLK following TPA and sodium butyrate treatment. All further experiments employed the iSLK cells, which permit efficient virus reactivation and virion production following doxycycline induction of RTA and sodium butyrate treatment (19, 28) . To assess the replication of BAC16-mCherry-ORF45 in comparison to that of the BAC16 wild type, we first induced the lytic cycle in infected iSLK cells. Proteins were extracted 24, 48, and 72 h after induction and analyzed by Western blotting. As shown in Fig. 2 and in line with previous reports, expression of ORF45 was induced following lytic induction. ORF45 migrated at a molecular mass corresponding to ϳ80 kDa in cell extracts harboring BAC16 wild-type virus, while an ϳ100-kDa band was detected for extracts from cells infected with BAC16-mCherry-ORF45. Similarly, anti-mCherry detected a band of ϳ100 kDa in extracts from BAC16-mCherry-ORF45-infected cells, which was induced upon reactivation. No cleavage products that reacted with mCherry antibody were evident, thereby enabling the tracking of this fluorescence as a marker for ORF45. Further incubation of this blot with antibodies to RTA, ORF K8, and GFP revealed similar levels of expression of these proteins following lytic induction, suggesting that the efficiency of lytic reactivation of BAC16-mCherry-ORF45 was similar to that of the BAC16 wild type. Moreover, quantitative real-time PCR, to test for viral DNA replication, revealed similar increases in KSHV DNA following induction of iSLK cells that were infected with either BAC16-mCherry-ORF45 or BAC16 (Fig. 2B) . In addition, TaqMan PCR that quantitated the relative amounts of encapsidated viral genomes found in pellets from supernatants that were collected from iSLK cells containing BAC16 and BAC16-mCherry-ORF45 revealed similar KSHV genome copy numbers. In agreement, we found that BAC16 and BAC16-mCherry-ORF45-infected iSLK cells produced similar numbers of infectious virions as measured by FACS analysis of the percentage of GFP-positive cells (data not shown). Taken together, our analyses indicate that BAC16-mCherry-ORF45 replicates with similar kinetics and to the same titers as its parental BAC16 strain, Agarose gel electrophoresis of wild-type BAC16 and recombinant BAC16-mCherry-ORF45. DNAs were digested and resolved on a 0.4% agarose gel stained with ethidium bromide. As predicted from HindIII and SnaB1 restriction patterns, the introduction of mCherry into BAC16 led to an increase in size from 5.8-and 9.9-kbp to 6.5-and 10.6-kbp fragments, respectively. Altered bands are indicated by asterisks. Molecular weight markers (M) (in thousands) are shown on the left. (C) Sequence analysis of the recombinant BAC16-mCherry-tagged ORF45 at the orf45-mCherry junctions (top, orf45 upstream and mCherry N terminus sequence; bottom, mCherry C terminus and orf45 coding sequence missing the original initiation codon following recombination).
indicating that the fluorescent tag does not interfere with the viral life cycle.
To determine whether mCherry-ORF45 is incorporated into KSHV virions, extracellular virions were harvested from the cell supernatant 96 h postinduction, and purified virions were lysed, resolved by SDS-PAGE, and analyzed by Western blotting with an anti-ORF45 monoclonal antibody (Fig. 3A) . Eighty kilodalton and ϳ100-kDa proteins were detected in virion lysates from BAC16 and BAC16-mCherry-ORF45, respectively, consistent with the expected molecular masses of ORF45 and mCherry-ORF45. Polyclonal antibodies to the small capsid protein ORF65, used as a loading control, detected a protein of 18 kDa in both virion types. Quantitative analysis of the signals obtained with the two antibodies by using ImageJ revealed a similar ORF45/ORF65 ratio for the two virion types, suggesting that the level of mCherry-ORF45 that is incorporated to virions is similar to that for the untagged ORF45. In addition, virion particles were bound to a glass coverslip and stained for ORF65. mCherry-ORF45 fluorescence was observed to overlap ORF65 and Hoechst staining in most particles, thus revealing that mCherry-ORF45 is incorporated into virions (Fig. 3B) . mCherry-ORF45 is first expressed in the nucleus and then in the cytoplasm during virus reactivation. Previous studies examined the cellular localization of ectopically expressed ORF45 in HEK-293T and BCBL-1 cells and found ORF45 to be expressed predominantly in the cytoplasm (20, 29, 30) . To determine the cellular localization of ORF45 in iSLK cells, we first introduced expression plasmids for GFP-or HA-tagged ORF45 into cells. As shown in Fig. 4 , transiently expressed GFP-or HA-tagged ORF45 demonstrated nuclear localization, or localization to both the nucleus and cytoplasm. A similar cellular distribution of ORF45 was evident in iSLK cells that were treated with doxycycline to induce the expression of RTA, suggesting that RTA does not affect the cellular distribution of ORF45.
To determine the cellular localization of ORF45 following virus reactivation, we induced lytic reactivation in BAC16-mCherry-ORF45-infected iSLK cells by treatment with doxycycline and sodium butyrate. Cells were fixed 24, 48, and 72 h postinduction, and the localization of ORF45 was examined by tracking the expression of mCherry. As shown in Fig. 5A , at 24 h following induction, mCherry-ORF45 was localized predominantly to the nucleus with a dot-like pattern. At 48 h postinduc- BAC16-mCherryORF45 were induced to undergo lytic virus reactivation using sodium butyrate and doxycycline. At 0, 24, 48, and 72 h following induction, whole-cell lysates were prepared, and protein expression of viral genes was analyzed by immunoblotting with the indicated antibodies against viral proteins as well as GFP. The same blot was also reprobed with anti-GAPDH as a loading control. (B) High-molecular-weight DNA was extracted at 0, 24, 48, and 72 h postinduction, and the copy number of KSHV genomes relative to cellular DNA was determined by quantitative TaqMan PCR. All values were normalized relative to noninduced BAC16-infected cells that were set as 1. The KSHV DNA level was normalized to that of purified host cellular DNA.
tion, mCherry-ORF45 appeared as fluorescent puncta that were localized in the nuclear margins, possibly inside or near the nuclear envelope, and within a structure adjacent to the nucleus which probably corresponds to the trans-Golgi network. At 72 h postinduction, mCherry-ORF45 appeared as punctum structures within the cytoplasm and at the cell periphery. The pattern of mCherry expression matched the fluorescent staining that was obtained with anti-ORF45, indicating that the localization of mCherry indeed signifies the expression of an mCherry-tagged ORF45 protein. To ensure that mCherry fusion to ORF45 did not affect its cellular distribution, we also examined the cellular localization of ORF45 following reactivation of BAC16-infected iSLK cells using antibodies directed against this protein. As shown in Fig. 5B , the cellular distribution of untagged ORF45 resembled the distribution of mCherry-ORF45. Further examination of the localization of ORF45 together with the minor capsid protein ORF65 (Fig. 6 ) demonstrated some overlap, though these proteins had somewhat different kinetics of expression and localization. At 24 h postinduction, ORF65 was expressed predominantly at nuclear domains that fully overlapped the localization of ORF45; ORF45 was also visible at additional nuclear sites. At later time points postinduction, we observed colocalization of ORF45 and ORF65 both at the nuclear margins and at the periphery of the cell. Since ORF45 was reported to interact with the motor protein KIF3A, which mobilizes proteins across microtubules, we also examined the association of mCherry-ORF45 with microtubules. As shown in Fig. 7 , mCherry-ORF45 punctum structures, which probably represent virions that move toward the cell periphery, colocalized with microtubules that were stained with anti-tubulin. Finally, by using live imaging, we have followed the dynamic localization of mCherry-ORF45 upon lytic reactivation. Static representative images are shown in Fig. 8 ; for the time series represented as an animation, see Movie S1 in the supplemental material. Early after lytic reactivation, mCherry fluorescence increased in intensity and was concentrated predominantly in foci which were distributed throughout the nucleus. Subsequently, mCherry localization was still observed in the nucleus, but in addition, we noticed recruitment of mCherry-ORF45 into the cytoplasm in an asymmetric dot-like perinuclear pattern reminiscent of the Golgi complex. This pattern displayed a high mobility and could signify vesicles containing progeny virions. At late time points, cell rounding occurred and the nuclear structure was twisted. This distribution of mCherry-ORF45 is consistent with those seen by immunoflu- orescence examination of fixed cells infected with the BAC16 wild type and BAC16-mCherry-ORF45.
Cellular localization of mCherry-ORF45 following infection. To determine the cellular localization of ORF45 at different time points postinfection, we infected iSLK cells with BAC16-mCherry-ORF45 at a multiplicity of infection (MOI) of 5 by spinoculation at 4°C and fixed the cells at 0, 2, 4, and 24 h postinfection. The localization of ORF45 was examined by tracking the expression of mCherry while the minor capsid protein ORF65 was identified with anti-ORF65. To control for incoming virion-associated mCherry-ORF45 and potential de novo expression of mCherry-ORF45, target cells were first treated with 5 g/ml actinomycin D 1 h prior to infection and during the infection course. The specificity of mCherry fluorescence was also confirmed in cells that were infected with BAC16. As shown in Fig. 9A , a similar distribution of mCherry was evident in infected cells that were either left untreated or treated with actinomycin D, thus indicating the virion source of mCherry fluorescence. No fluorescent signal was evident when cells were infected with the control virus BAC16, indicating the specificity of the mCherry fluorescence. As shown in Fig. 9B , extracellular virions, identified by anti-ORF65 staining and mCherry-ORF45 fluorescence, appeared as discrete fluorescent puncta and were mostly localized adjacent to the cell surface immediately postspinoculation. Of note, although virus infection was carried at an MOI of 5, numerous particles surrounded the cells, thus emphasizing the high ratio of particles to infectious units for the KSHV stocks (19) . At 2 h postinfection, fluorescent puncta were detected in the cytosol and at the nuclear rim. The majority of ORF65-stained capsids in the cytosol contained mCherry-ORF45, whereas capsids that reached the nuclear rim lacked mCherry fluorescence, suggesting the dissociation of ORF45 from incoming virions. By 4 h postinfection, most capsids could be seen in the cytosol or at the nuclear rim. At 24 h postinfection, faint mCherry puncta, independent of ORF65, were detected in the cytosol, suggesting possible degradation of free mCherry-ORF45. These findings provide evidence for the association of ORF45 tegument protein with incoming capsids in the cytosol and its dissociation as the capsids move toward the nucleus.
Evaluation of KSHV lytic reactivation levels by quantification of mCherry-positive cells. To demonstrate the ability of mCherry-ORF45 to identify lytic infection and to be used as a marker for this phase, BAC16-mCherryORF45-infected iSLK cells were treated with doxycycline alone, or combined with TPA, sodium butyrate, or valproic acid, for 24 and 48 h. Cells were collected, and the percentage of GFP-and mCherry-positive cells was determined by FACS analysis. As shown in Fig. 10 and in line with previous results (19) , under standard growth conditions, almost no mCherry-expressing cells were observed. Roughly 11% of cells expressed mCherry 24 and 48 h after induction of RTA expression by treatment with doxycycline. The effect of doxycycline was further enhanced when combined with chemical inducers, as there were up to 87% mCherry-positive cells 48 h after combined treatment with doxycycline and sodium butyrate. These results are in agreement with previous results in which the red fluorescent protein (RFP) gene from the PAN RNA promoter was used as a marker for the inducibility of iSLK cells (19) .
DISCUSSION
In most experimental cell cultures, KSHV infection results in the establishment of a latent infection in which infected cells cannot be readily distinguished from uninfected ones. Furthermore, cells undergoing lytic reactivation cannot be distinguished based on their morphology, in particular during the early phases. Recombinant viruses that express fluorescent proteins commonly serve as important tools to track viral infection and to elucidate the intracellular trafficking of virions and subviral particles. Indeed, a recombinant dual-color KSHV (rKSHV.219), designed to consti- tutively express GFP as a marker of infection and RFP under the control of the strong early lytic promoter PAN, enables the identification of KSHV-infected cells and the discrimination of cells undergoing lytic infection by using fluorescence microscopy or FACS analysis (31) . BAC16, a full-length KSHV genome BACcontaining clone, was derived from rKSHV.219 by replacing the GFP and RFP cassettes; this construct can be stably propagated in bacteria and produces infectious virions upon reconstitution in mammalian cells (21) . This clone constitutively expresses GFP in mammalian cells. Here, we report the construction of a recombinant dual-color KSHV genome, which constitutively expresses GFP and contains the fluorescent protein mCherry that tags the tegument protein ORF45.
Several assays were used to ensure that the BAC16-mCherry-ORF45 was properly expressed. First, the presence of the fusion protein in lysates from cells that were induced into lytic phase was assessed by Western blot analysis using an antibody directed against mCherry. Second, structural incorporation of the mCherry-ORF45 fusion to KSHV virions was confirmed by Western blot analysis and confocal fluorescent imaging. BAC16-mCherry-ORF45 DNA established a latent infection in iSLK cells, expressed the viral lytic proteins upon reactivation, and produced infectious virions at a level similar to that of its parental BAC16 clone. Furthermore, the cellular localization of mCherry-ORF45 fully matched that of the authentic untagged ORF45, and an absolute overlap between the mCherry fluorescence and the anti-ORF45 fluorescent signal was documented. Therefore, our results suggest that BAC16-mCherry-ORF45 can be used to monitor ORF45 during infection and to follow infected cells that undergo lytic infection with KSHV. As such, the expression of GFP marks infected cells, while induction of early viral lytic gene expression can be followed by mCherry expression. However, this approach cannot be implemented for all KSHV-infected cell types, and the classification of ORF45 as a lytic gene product must be confirmed in each experimental setting. In fact, mTORC1 activation and rapamycin sensitivity of KSHV-infected primary dermal and lung human lymphatic endothelial cells (LECs) was recently demonstrated and attributed to the latent expression of ORF45 in these cells (32) . ORF45 is a multifunctional protein which has been classified as an immediate early gene product that is expressed in most experimental models during the lytic infection phase through RTAdependent and independent mechanisms (33, 34) . ORF45 is also incorporated into the virion tegument (17, 30) . The identification of molecular interactions of ORF45 with cellular proteins advanced the understanding of its functions during infection. The interaction of ORF45 with interferon regulatory factor 7 (IRF-7) antagonizes the type I interferon host antiviral responses through the inhibition of IRF-7 phosphorylation and nuclear translocation (35) (36) (37) . ORF45 forms complexes with p90 ribosomal S6 kinase (RSK1 and RSK2) and extracellular signal-regulated kinase (ERK), stimulating the phosphorylation of nuclear and cytoplasmic proteins, including the eukaryotic translation initiation factor 4B (eIF4B) (38) (39) (40) . This function has been suggested to increase productive infection and to render infected LECs dependent on the mTORC1 pathway (32) . ORF45 also interacts with the microtubule plus-end-directed motor protein KIF3A, which functions as a kinesin-2 subunit, transporting cargo from the nucleus to the cell periphery along microtubules. This interaction presumably contributes to the docking and transport of the newly synthesized nucleocapsids along microtubules and thus implicates ORF45 in viral egress (41) . The above functions are most likely exerted in various cellular compartments and appear to be important for efficient productive infection, for establishment of latency, and in mediating robust lytic reactivation.
Our study found mCherry-ORF45 predominantly in the nucleus at early time points post-lytic reactivation, with a small fraction of the protein present in the cytoplasm. At later time points, mCherry-ORF45 was localized to the periphery of the nucleus and close to the cell plasma membrane, as well as to a structure near the nucleus, which probably represents the trans-Golgi network. The authenticity of this cellular distribution was confirmed by using immunofluorescent staining with anti-ORF45 antibodies. We and others reported previously that KSHV ORF45 is found predominantly in the cytoplasm (20, 29, 35) ; however, accumulation of ORF45 in the nucleus after inhibition of CRM1-dependent nuclear export and shuttling of ORF45 between the nucleus and the cytoplasm during infection were previously reported as well (42) . Nuclear localization of ORF45, which was documented with a viral replication compartment, in primary effusion lymphoma cells has been reported (40) . Interestingly, recombinant viruses in which ORF45 is restricted to the nucleus behave normally, whereas recombinant KSHV in which ORF45 is restricted to the cytoplasm behaves similarly to ORF45-null mutant viruses, suggesting that ORF45 has an essential nuclear function (42) . Given the nuclear localization of ORF45 homologs encoded by other members of the Gammaherpesvirinae, they are likely to share common functions in the nucleus. The present study demonstrates dynamic localization of ORF45 during lytic reactivation. In contrast, ectopically expressed protein maintained a steady cellular localization that was not affected by the expression of RTA. These results highlight the advantage of studying viral proteins within the context of infection. The dynamics are likely to reflect the various functions of ORF45 and possibly its unique protein interactions and posttranslational modifications during the different phases of infection.
In summary, this study presents the assembly and initial characterization of a new dual-color fluorescently labeled KSHV virus, which can be used to track cells that undergo lytic infection. As was already done for other viruses (43) , the BAC16-mCherry-ORF45 recombinant virus can also be used to address issues related to the trafficking and maturation pathways of KSHV virions following de novo infection or during reactivation. Specifically, it may allow the identification of the phases of infection at which ORF45 assembles or disassembles and thus may confirm its candidacy as an effector of capsid transport during ingress and egress. Furthermore, as shown in the present study, this virus can serve as a platform for digital time-lapse microscopy experiments with living cells. These experiments are expected to provide insights into the dynamics of intracellular transport of KSHV capsids and their tegumentation and detegumentation, thereby highlighting key pathways that are activated during the various phases of KSHV infection.
